Matteo Zampini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Journal: HemaSphere

Published: October 21, 2025

PU.1-activated genomic regions define low-risk MDS subsets characterized by immune dysregulation and disease progression.

PU.1-activated genomic regions define low-risk MDS subsets characterized by immune dysregulation and disease progression.

Journal: Blood

Published: July 15, 2025

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes.

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 02, 2025

Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).

Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).

Journal: International journal of molecular sciences

Published: September 26, 2024

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology.

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology.

Journal: JCO clinical cancer informatics

Published: June 30, 2023

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 17, 2023

The Genetics of Myelodysplastic Syndromes: Clinical Relevance.

The Genetics of Myelodysplastic Syndromes: Clinical Relevance.

Journal: Genes

Published: May 20, 2021

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Journal: Blood

Published: February 16, 2021

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 04, 2021

A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.

A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.

Journal: British journal of haematology

Published: September 30, 2017

Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML.

Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML.

Journal: Leukemia

Published: September 19, 2017

The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.

The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.

Journal: Molecular cancer

Published: February 21, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026